Scheilly Tsilova PhD joins as Senior Pharmaceutical Scientist
We’re delighted to welcome Scheilly Tsilova, Ph.D to the Calla Lily Clinical Care team as our new Senior Pharmaceutical Scientist. 🥼 For the past two years, Scheilly has been instrumental in advancing our Callavid® vaginal drug delivery technology while pursuing her PhD at UCL, with a focus on polymer-based drug delivery systems. Her deep technical …
ACOG in Minneapolis
Spending time in Minneapolis for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting was even better than I had hoped. Besides the constant engagement with passionate American OBGYNs (so many of which are excited to hear about our Callavid® drug delivery technology) – it was superb to connect with other …
HLTH Europe Startup Finalist
Delighted to be named a 2025 finalist in the HLTH Europe Startup Pitch, sponsored by Haleon! Honoured to share the stage with some of the most innovative healthtech startups in Europe. See you in Amsterdam. 🇳🇱
Naomi Aduroja joins as a Roivant Social Ventures Global Access Fellow
💥 A warm welcome to Naomi Aduroja who joins us as a Roivant Social Ventures Global Access Fellow this summer. Currently preparing for her third year in the prestigious PharmD program at UNC Eshelman School of Pharmacy – we’re delighted to have Naomi support various R&D projects leaning on her experience including from across pharmacy …
ACOG Clinical & Scientific Meeting in Minneapolis
We’re delighted to be in Minneapolis for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting. From May 16th-18th, we’ll be ready to connect, collaborate, and showcase our Callavid® vaginal drug delivery innovation at the largest meeting of obstetricians and gynecologists in the US. This is an exciting opportunity to discuss …
Discover CLCC’s B Corp Impact Report
We believe that true success in business must be measured not just by commercial milestones, but by the positive impact we create. To us, being a B Corp is more than a certification – it’s a daily commitment to balancing people, planet, profit, and purpose. B Lab’s rigorous standards provide a clear framework for accountability …
CLCC awarded £1m NIHR funding to address threatened miscarriage
Pioneering technology to address threatened miscarriage secures £1 million funding and moves towards clinical trials • Scientists developing a pioneering device designed to address threatened miscarriage have secured £1 million in NIHR funding to begin clinical trials • Designed to deliver vital doses of progesterone, the Callavid® device stands to help over 150,000 women each …
Int’l Women’s Day
A slightly belated nod to International Women’s Day (as we’ve just taken this 📸 )— but still just in time for Women’s History Month. I want to take a moment to share how incredibly grateful I am to work alongside such a brilliant, dedicated, and inspiring group of women at Calla Lily Clinical Care 🔬 It’s …
China & Manufacturing Patent Grants
We’ve achieved some exciting IP milestones for Calla Lily Clinical Care; making strong progress in building a robust IP strategy and IP portfolio to protect and advance our innovations in women’s health. 💥 China Patent Grant for our Drug Delivery Device 🌏 At long last, one of our vaginal drug delivery applications in China has …
SXSW Conference in Austin
Calla Lily Clinical Care is excited to be in Austin for SXSW! 🇺🇲 This dynamic conference & festival celebrates the convergence of tech, film, music, and culture while empowering creatives to achieve their goals. We’re excited to connect with like-minded innovators across these different industries who share our commitment to elevating women’s health. If you’re …